| 12/2/2024 | CVLM | Bilibili buys back $419.11 million of 0.5% convertibles due 2026
|
| 10/21/2024 | CVLM | Bilibili announces repurchase right for 0.5% convertibles due 2026
|
| 2/20/2024 | CVLM | Bilibili announces repurchase right for 1.375% convertibles due 2026
|
| 8/18/2023 | BWCVEMLM | Bilibili has ample cash for convertibles, operations after repurchase
|
| 6/14/2023 | CVLM | Bilibili repurchases $745.91 million 1.25% convertibles due 2027
|
| 1/9/2023 | CV | Market Commentary: Live Nation convertible notes upsized amid heavy demand; talk tightens; Bilibili active
|
| 1/9/2023 | CVLM | Bilibili prepares exchange offer for 0.5% convertibles due 2026
|
| 1/9/2023 | CV | Market Commentary: Morning Commentary: Live Nation convertibles offering reactivates primary; demand heavy
|
| 1/6/2023 | CV | Market Commentary: Convertibles sideways as equities rip; Asian convertible notes bid up; health care eyed
|
| 1/6/2023 | CV | Market Commentary: Morning Commentary: Asian convertible notes eyed in early trading as stocks rally
|
| 11/29/2022 | CV | Market Commentary: Asian convertible issuers in focus; Bilibili, ZTO, Li Auto, Pinduoduo notes gain
|
| 10/11/2022 | CV | Market Commentary: Northern Oil and Gas plays to solid demand; Bilibili active; Alnylam hits new low
|
| 5/31/2022 | CV | Market Commentary: ConMed convertibles on tap; Asian names rally; Pinduoduo jumps; Insulet up on swap
|
| 5/31/2022 | CV | Market Commentary: Morning Commentary: Bilibili convertible notes active early, gain on quiet morning
|
| 4/29/2022 | CV | Market Commentary: Accolade convertibles sink as stock plunges post earnings; Bilibili better; Liberty eyed
|
| 3/22/2022 | CV | Market Commentary: ADR names gain as buyers return to the space; Snap convertibles top par; Innoviva active
|
| 3/21/2022 | CV | Market Commentary: Snap convertible notes in focus, volatile; Block pulls back; Bilibili, Sea active
|
| 3/16/2022 | CV | Market Commentary: Secondary tone improves; Pinduoduo, Bilibili convertible notes rebound; airlines gain
|
| 3/16/2022 | CV | Market Commentary: Morning Commentary: Pinduoduo, Bilibili convertible notes rebound in early trading
|
| 3/10/2022 | CV | Market Commentary: Travere Therapeutics convertibles tick higher; China-based issuers under pressure
|
| 2/9/2022 | CV | Market Commentary: Snap ‘name of the day’; new convertible notes expand on debut; Xometry notes jump
|
| 1/27/2022 | CV | Market Commentary: Bilibili convertibles pressured; EV makers drop on Tesla production delays; Coupa active
|
| 1/27/2022 | CV | Market Commentary: Morning Commentary: ADR convertible notes active in early secondary trading
|
| 1/4/2022 | CV | Market Commentary: Sea convertible notes in focus as equity plummets; Ford gains; Affirm hits new low
|
| 12/21/2021 | CV | Market Commentary: Convertibles secondary bid up; Expedia, Southwest Airlines eyed; Bilibili, Luminar gain
|
| 12/6/2021 | CV | Market Commentary: Pinduoduo, Affirm convertibles improve outright; Bilibili active; JetBlue contracts
|
| 12/6/2021 | CV | Market Commentary: Morning Commentary: Bilibili, Affirm convertible notes in focus in early trading
|
| 12/3/2021 | CV | Market Commentary: DocuSign convertibles expand as stock slaughtered; China convertibles under pressure
|
| 12/3/2021 | CV | Market Commentary: Morning Commentary: DocuSign expands as stock slaughtered; China convertible notes eyed
|
| 12/2/2021 | CV | Market Commentary: Lithium Americas convertibles expand on debut; Affirm, Bilibili drop further below par
|
| 11/23/2021 | CV | Bilibili greenshoe lifts 0.5% convertibles due 2026 to $1.6 billion
|
| 11/22/2021 | CV | Market Commentary: Affirm, DigitalOcean convertibles below par; Bilibili up; Vonage skyrockets on buyout
|
| 11/22/2021 | CV | Market Commentary: Morning Commentary: Affirm convertibles trade below par; Bilibili gains in early trading
|
| 11/19/2021 | CV | Market Commentary: Convertibles secondary supply surges; Camtek, Arrival, Affirm gain; Bilibili contracts
|
| 11/19/2021 | CV | Market Commentary: Morning Commentary: Convertibles secondary sees supply surge; Camtek, Arrival, Affirm up
|
| 11/19/2021 | CV | New Issue: Bilibili prices $1.4 billion five-year convertible notes to yield 0.5%, up 40%
|
| 11/18/2021 | CV | Market Commentary: Affirm, Bilibili, Camtek convertibles eyed; Arrival upsizes; Stem hits aftermarket
|
| 11/18/2021 | CV | Market Commentary: Morning Commentary: Affirm, Bilibili, Camtek convertibles eyed; Stem hits aftermarket
|
| 11/18/2021 | CV | Bilibili talks $1.4 billion five-year convertible notes to yield 0%-0.5%, up 40%-45%
|
| 6/30/2020 | CV | Market Commentary: II-VI’s mandatory convertible preferreds eyed; second-quarter issuance breaks records
|
| 6/2/2020 | CV | Bilibili greenshoe lifts seven-year convertibles to $800 million
|
| 6/1/2020 | CV | Market Commentary: Splunk notes on deck; Livongo, HubSpot convertible offerings eyed; Bilibili tops par
|
| 5/29/2020 | CV | Market Commentary: Datadog, Cerence convertibles expand; Bilibili contracts; May volume highest since 2009
|
| 5/29/2020 | CV | Market Commentary: Morning Commentary: Datadog, Cerence convertibles expand; Bilibili contracts on debut
|
| 5/29/2020 | CV | New Issue: Bilibili prices upsized $700 million seven-year convertibles to yield 1.25%, up 32.5%
|
| 5/28/2020 | CV | Market Commentary: Bilibili, Cerence convertibles eyed; Datadog upsizes; Air Canada, Silicon Labs expand
|
| 5/28/2020 | CV | Market Commentary: Morning Commentary: Bilibili, Cerence, Datadog eyed; new deals make aftermarket debut
|
| 5/27/2020 | CV | Market Commentary: Bilibili, Cerence on tap; Silicon Labs, NuVasive, Air Canada eyed; 1Life Healthcare down
|
| 5/27/2020 | CV | Bilibili talks $650 million seven-year convertible notes to yield 0.75%-1.25%, up 32.5%-37.5%
|
| 1/2/2020 | CV | Market Commentary: Markets firm in new year; Lumentum, RingCentral active; China-based converts gain
|
| 7/2/2019 | CV | Market Commentary: Convertibles trading light; China-based convertibles in focus; DISH Network active
|
| 6/10/2019 | CV | Market Commentary: Calendar balloons; Dominion Energy, Vonage, Zynga on tap; Coupa Software gains continue
|
| 6/10/2019 | CV | Market Commentary: Morning Commentary: Coupa Software remains in focus; China-based convertibles active
|
| 4/16/2019 | CV | Market Commentary: Aphria on tap; Aqua America eyed; Western Digital convertibles in focus; PDL Biopharma active
|
| 4/16/2019 | CV | Market Commentary: Morning Commentary: Convertibles trading volume light; Bilibili below par; iQIYI active
|
| 4/12/2019 | CV | Market Commentary: Ensco convertibles gain post-merger; Bilibili closes week above par; PAR Technology up
|
| 4/12/2019 | CV | Market Commentary: Morning Commentary: Ensco convertibles in focus post-merger; Bilibili back below par
|
| 4/8/2019 | CV | Market Commentary: Convertibles trading light; Dermira notes improve; Fortive active in secondary market
|
| 4/8/2019 | CV | Bilibili greenshoe exercised in full, ups 1.375% seven-year convertible notes to $500 million
|
| 4/5/2019 | CV | Market Commentary: Baozun’s new converts hit the market, trade ‘all over the place’; Bilibili returns to par; Ensco improves
|
| 4/4/2019 | CV | Market Commentary: Baozun looks cheap; Bilibili drops below par; Tesla converts in focus, contract slightly
|
| 4/4/2019 | CV | Market Commentary: Morning Commentary: Baozun on tap; Bilibili comes in; Tesla in focus
|
| 4/3/2019 | CV | Market Commentary: Bilibili’s new convertibles expand on debut; iQIYI, Citrix active; Chegg breaks par
|
| 4/3/2019 | CV | Market Commentary: Morning Commentary: Bilibili’s new convertibles dominate secondary, expand on debut
|
| 4/3/2019 | CV | New Issue: Bilibili prices upsized $430 million seven-year converts to yield 1.375%, up 37.5%
|
| 4/2/2019 | CV | Market Commentary: Bilibili convertible notes offering eyed; iQIYI remains in focus; Ensco gains
|
| 4/2/2019 | CV | Market Commentary: Morning Commentary: Bilibili convertible notes offering eyed
|
| 4/1/2019 | CV | Market Commentary: Bilibili on tap; iQIYI convertibles in focus; RH active; Chinese-based convertibles up
|
| 4/1/2019 | CV | Bilibili talks $300 million seven-year converts to yield 1.375% to 1.875%, up 32.5% to 37.5%
|
